Cannabis control and the right to privacy

In 2018 the highest courts in countries across three continents have asserted that state intervention in the private life of their citizens who wish to (grow and) use cannabis is not always justified. 03.01.2019 
Čtěte více

Registration now open for the eighth European drugs summer school

Upcoming ISCTE-IUL–EMCDDA summer school: 24 June–5 July 2019 18.12.2018  The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces once again next summer to hold the eighth European drugs summer school (EDSS) on ‘Illicit drugs in Europe: demand, supply and public policies’ (1). Registration is now open for the two-week course, which will take place in the Portuguese capital from 24 June to 5 July (2). The initiative is also supported by the US National Institute on Drug Abuse (NIDA)(3).
Čtěte více

Signature of working arrangements with five EU agencies

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) has been significantly strengthened thanks to new legislation applying from 23 November (1). The legislation strengthens the EU Early Warning System (EU EWS) and risk assessment procedures on NPS and shortens control processes. 06.12.2018 
Čtěte více

EU drugs agency publishes its first report on the medical use of cannabis

Drug policy: medical use of cannabis in Europe 04.12.2018  What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? These and other questions are explored in a new report published today by the EU drugs agency (EMCDDA): Medical use of cannabis and cannabinoids: questions and answers for policymaking.
Čtěte více